Genentech Inc.


Considered the founder of the industry, Genentech has been delivering on the promise of biotechnology for more than 40 years, discovering and developing innovative medicines to treat people with serious and life-threatening medical conditions. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. Genentech is a member of the Roche Group, headquartered in South San Francisco, California.


Exhibitor Level: 
Andrew Craigie Circle
Booth Number: 
Exhibitor Type: 
Biotechnology Pharmaceuticals